Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)

University of Washington

Status

Completed

Conditions

Alzheimer's Disease

Cognitive Impairment

Memory Impairment

Dementia

Treatments

Behavioral: RDAD

Study type

Interventional

Funder types

Other

Identifiers

NCT01708304

41906

Details and patient eligibility

About

The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.

Enrollment

510 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Care Recipients must

Have a diagnosis of dementia
Be 65 years of age or older
Currently exercise no more than 150 minutes a week and not regularly participate in a formal exercise program.

Caregivers must

Live in the community
Provide care to the care recipient with dementia

Exclusion criteria

Either Care-recipient or Caregiver must not

Plan to move to a long-term residential care setting within 6 months of enrollment.
Plan to move from the study geographic area within 4 months of enrollment.
Have a known terminal illness (with death anticipated within the next 12 months)
Have had a hospitalization for a psychiatric disorder in the 12 months prior to baseline
Be actively suicidal, hallucinating, or delusional
Be blind, deaf, or not ambulatory